Table 13.
Government cost for chronic Lyme disease for the USA for 2018 if governments do not finance IV treatment with antibiotics for chronic Lyme disease.
| Government costs for chronic Lyme disease for the USA for 2018 if the government does not finance IV treatment for chronic Lyme disease | |||
| Values | |||
| Number of Lyme disease infections 2018 in the USA | 1 011 278 | ||
| People infected with Borrelia that develop chronic Lyme | 0.63 | % | |
| Number of chronic infections in the USA for 2018 | 637 105 | ||
| % of chronic Lyme patients that does not work | 0.42 | % | |
| % of chronic Lyme patients that does work | 0.58 | ||
| Average annual income from work before tax for the USA for 2016 | 60 154 | USD | |
| Income tax rate for the USA for 2016 | 0.396 | % | |
| Average annual disability benefits after tax for the USA for 2017 | 14 052 | USD | |
| Lost personal income for chronic Lyme patients not working in the USA for 2018 | 16 096 253 841 | 16.1 | billion USD |
| Lost tax revenues because chronic Lyme patients are not working in the USA in 2018 (LTR USA 2018) | 6 374 116 521 | 6.4 | billion USD |
| Disability benefits for chronic Lyme patients for the USA for 2018 (DB USA 2018) | 3 760 091 747 | 3.8 | billion USD |
| Government cost for chronic Lyme disease for the USA in 2018 (GCL USA 2018) = LTR USA 2018 + DB USA 2018 | 10 134 208 268 | 10.1 | billion USD |
| GCL USA 2018 / IV0.5 USA 2018 | 2.1 | ||
| GCL USA 2018 / IV1 USA 2018 | 1.1 | ||